/Cencora%20Inc_%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Cencora, Inc. (COR), headquartered in Pennsylvania, is a global pharmaceutical sourcing and distribution leader offering innovative healthcare solutions and services. With a market cap of $45.2 billion, customer-centric strategies, and sustainable practices, Cencora plays a pivotal role in advancing healthcare access and outcomes worldwide. Catering to a diverse range of healthcare providers and patients, the company is poised to report its Q1 earnings fiscal 2025 on Wednesday, Jan. 29.
Ahead of the event, analysts expect Cencora to report a profit of $3.50 per share, up 6.7% from $3.28 in the year-ago quarter. The company has consistently surpassed Wall Street’s adjusted EPS projections in each of the past four quarters.